Comparative effectiveness of bone grafting vs. total hip arthroplasty in non-traumatic osteonecrosis of femoral head: a 5-year follow-up study with patient-reported outcomes

To compare mid-term survival and health-related quality of life differences between bone grafting (BG) and total hip arthroplasty (THA) in non-traumatic osteonecrosis of the femoral head (NTONFH) patients under 50 years of age. This single-center retrospective study analyzed 165 consecutive NTONFH patients (2015–2020) undergoing BG (n = 55) or THA (n = 110). Primary outcomes were 5-year survival (revision endpoint), with secondary outcomes including Harris Hip Score, complications, and patient-reported measures (SF-36, JHEQ, UCLA). Survival analysis employed log-rank tests and Cox proportional hazards model. The THA group exhibited significantly higher 5-year survival rates than the BG group (95.5% vs. 81.8%, p = 0.003). The THA group demonstrated superior postoperative HHS total scores (91.3 ± 3.2 vs. 82.1 ± 6.7, p < 0.001), pain scores (42.8 ± 1.6 vs. 40.1 ± 3.2, p < 0.001), and physical activity levels (UCLA: 7.2 ± 1.5 vs. 6.5 ± 1.8, p = 0.018). However, the BG group outperformed in mental health domains: SF-36 mental component score (65.8 ± 13.2 vs. 58.4 ± 14.7, p = 0.021) and JHEQ mental score (24.3 ± 4.9 vs. 20.7 ± 5.6, p = 0.004). Subgroup analysis revealed comparable survival rates between BG and THA in ARCO IIIA-stage patients (87.2% vs. 94.6%, p = 0.672), while BG failure rates reached 44.4% in JIC C2-type patients. THA offers advantages in functional recovery and survival rates, but rigorously selected ARCO IIIA-stage patients undergoing BG achieve comparable survival outcomes to THA while exhibiting superior mental health benefits. BG is recommended for ARCO II-IIIA/JIC A-C1-type patients to preserve joint function and enhance psychosocial adaptation, whereas THA remains the optimal choice for advanced-stage (IIIB/IV) or JIC C2-type patients to ensure rapid functional restoration. This study provides evidence for personalized treatment strategies based on disease staging, anatomical severity, and patient psychological needs.

Authors

Institutions

Publication Details

Journal
BMC Musculoskeletal Disorders
Published
2025-12-19
DOI
https://doi.org/10.1186/s12891-025-09415-z
Primary Topic
Bone and Joint Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative effectiveness of bone grafting vs. total hip arthroplasty in non-traumatic osteonecrosis of femoral head: a 5-year follow-up study with patient-reported outcomes

Chen Chang-xian, Y Wang, Zhaoke Wu, Changyu Huang et al.
BMC Musculoskeletal Disorders
Bone and Joint Diseases
article

Comparative effectiveness of bone grafting vs. total hip arthroplasty in non-traumatic osteonecrosis of femoral head: a 5-year follow-up study with patient-reported outcomes

Chen Chang-xian, Y Wang, Zhaoke Wu, Changyu Huang, Zhikun Zhuang, Zhi-Bing Gong, Hsin‐Hung Lin, Xian-Liang Lai
article en

Abstract

To compare mid-term survival and health-related quality of life differences between bone grafting (BG) and total hip arthroplasty (THA) in non-traumatic osteonecrosis of the femoral head (NTONFH) patients under 50 years of age. This single-center retrospective study analyzed 165 consecutive NTONFH patients (2015–2020) undergoing BG (n = 55) or THA (n = 110). Primary outcomes were 5-year survival (revision endpoint), with secondary outcomes including Harris Hip Score, complications, and patient-reported measures (SF-36, JHEQ, UCLA). Survival analysis employed log-rank tests and Cox proportional hazards model. The THA group exhibited significantly higher 5-year survival rates than the BG group (95.5% vs. 81.8%, p = 0.003). The THA group demonstrated superior postoperative HHS total scores (91.3 ± 3.2 vs. 82.1 ± 6.7, p < 0.001), pain scores (42.8 ± 1.6 vs. 40.1 ± 3.2, p < 0.001), and physical activity levels (UCLA: 7.2 ± 1.5 vs. 6.5 ± 1.8, p = 0.018). However, the BG group outperformed in mental health domains: SF-36 mental component score (65.8 ± 13.2 vs. 58.4 ± 14.7, p = 0.021) and JHEQ mental score (24.3 ± 4.9 vs. 20.7 ± 5.6, p = 0.004). Subgroup analysis revealed comparable survival rates between BG and THA in ARCO IIIA-stage patients (87.2% vs. 94.6%, p = 0.672), while BG failure rates reached 44.4% in JIC C2-type patients. THA offers advantages in functional recovery and survival rates, but rigorously selected ARCO IIIA-stage patients undergoing BG achieve comparable survival outcomes to THA while exhibiting superior mental health benefits. BG is recommended for ARCO II-IIIA/JIC A-C1-type patients to preserve joint function and enhance psychosocial adaptation, whereas THA remains the optimal choice for advanced-stage (IIIB/IV) or JIC C2-type patients to ensure rapid functional restoration. This study provides evidence for personalized treatment strategies based on disease staging, anatomical severity, and patient psychological needs.

BMC Musculoskeletal DisordersVol. 26(1)
Fujian University of Traditional Chinese Medicine (CN), Quanzhou Normal University (CN), Quzhou City People's Hospital (CN), The 180th Hospital of PLA (CN)
Natural Science Foundation of Fujian Province
Openalex Percentile: Top 49%
Bone and Joint Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.